High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution (Q41723913)

From Wikidata
Jump to navigation Jump to search
scientific article published on June 2011
edit
Language Label Description Also known as
English
High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution
scientific article published on June 2011

    Statements

    High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution (English)
    D C Seldin
    N Andrea
    I Berenbaum
    J L Berk
    L M Dember
    G Doros
    S Fennessey
    S Girnius
    A Lerner
    C Libbey
    H K Meier-Ewert
    R O'Connell
    C O'Hara
    K Quillen
    F L Ruberg
    A Segal
    A Shelton
    M Skinner
    J M Sloan
    J F Wiesman
    V Sanchorawala
    1 June 2011
    18 Suppl 1
    127-129

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit